BackgroundConventional 40 Hz gamma stimulation is applied across individuals, potentially overlooking inter-individual neural variability.ObjectiveThis study evaluated conversation gamma frequency (CGF)–a personalized gamma frequency derived from task engagement–against the fixed 40 Hz and individual gamma frequency (IGF) derived from auditory responses.MethodsIn Experiment 1, gamma center frequencies were measured under resting, reading, and conversation conditions. In Experiment 2, EEG was used to compare neural entrainment effects across CGF, 40 Hz, and IGF conditions.ResultsConversation gamma frequency stimulation induced stronger neural activation and functional connectivity in the frontal, temporal, and parietal cortices compared to 40 Hz or IGF. Theta-gamma coupling analysis revealed significantly increased phase synchronization under CGF compared to 40 Hz with enhanced connectivity. However, entrainment declined as the frequency difference between CGF, and 40 Hz increased, emphasizing the limitation of fixed-frequency stimulation.ConclusionThese findings provide EEG-based mechanistic evidence that individualized gamma stimulation may represent a hypothesis-generating strategy for future neurorehabilitation research in aging and neurodegenerative conditions.
Correction: Prevalence of body-focused repetitive behaviors among the general population of Saudi Arabia: a cross-sectional study
Sequence Display enables large-scale sequence–activity datasets for rapid protein evolution
Nature Biotechnology, Published online: 08 April 2026; doi:10.1038/s41587-026-03087-3
Sequence Display maps protein variant activities to a sequencing-based readout.
The patient as partner: Can the NHS learn from the high street?
We need to treat patients as partners in a journey, writes Lee Rickles, CIO at Humber Teaching Foundation Trust
<![CDATA[Explore today’s narcolepsy care: wake-promoting meds, oxybates for cataplexy, and pitolisant’s histamine boost—plus sleep habits that matter.]]>
<![CDATA[Explore glutamate-based depression treatments—esketamine and dextromethorphan-bupropion—boost synaptogenesis and deliver fast relief when monoamines fail.]]>
<![CDATA[Explore today’s narcolepsy care: from sleep hygiene to stimulants, oxybates, and pitolisant—targeting sleepiness and cataplexy.]]>
<![CDATA[Why settle for “less bad”? Clinicians urge aggressive depression care aimed at true remission, balancing side effects and patient priorities.]]>
What does MAHA look like these days?
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here.
Good morning. I’ve got a couple fun programming notes for you. The “First Opinion Podcast” is back! This season will focus on the intersection between culture and medicine, and opens with an episode on sports betting.
London NHS trusts to roll out AI scribing to 20,000 clinicians
Four NHS trusts in south west London will deploy ambient voice technology (AVT) from Lyrebird Health across the region.

